The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD)

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD)'. Together they form a unique fingerprint.

Medicine & Life Sciences